M&A Deal Summary |
|
|---|---|
| Date | 2020-05-22 |
| Target | Temsa |
| Sector | Automotive |
| Buyer(s) |
PPF Group
Haci Omer Sabanci Holding A.S. |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
PPF Group is a diversified, family-backed international investment group founded in the Czech Republic, with its strategic headquarters registered in the Netherlands. The Group operates and invests across Europe, North America, and Asia—investing in sectors including financial services, communications, media, real estate, life science, and e-commerce. PPF Group was formed in 1991 and is based in Amsterdam.
| DEAL STATS | # |
|---|---|
| Overall | 13 of 18 |
| Sector: Automotive M&A | 1 of 1 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 8 of 11 |
| Country: Turkey M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-10-27 |
Central European Media Enterprises
Hamilton, Bermuda Central European Media Enterprises is an Eastern European free-to-air TV company that owns and operates a portfolio of commercial TV stations in six Eastern European countries, reaching approximately 82 million people across the Czech Republic, Romania, Slovenia, Slovak Republic, Croatia, and Bulgaria. Central European Media Enterprises is based in Hamilton, Bermuda. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-12-10 |
NBE-Therapeutics AG
Basel, Switzerland NBE-Therapeutics is a privately-owned Swiss biotech company based in Basel and founded in 2012 with the vision of developing next-generation immune-stimulatory antibody-drug conjugate (iADC) products. NBE-Therapeutics advances its products to clinical proof of concept with the goal of improving treatment options for cancer patients. The company leverages proprietary platforms covering all aspects of ADC development: its Transpo-mAb Display technology for antibody discovery, its SMAC-Technology for site-specific payload conjugation of toxins to antibodies, and a novel highly effective and immune-stimulatory anthracycline-based toxin platform. |
Sell | €1.2B |
| Category | Company |
|---|---|
| Founded | 1967 |
| Sector | Diversified |
| Employees | 59,517 |
Haci Omer Sabanci Holding A.S., through its subsidiaries, operates in various fields, including mainly finance, manufacturing, and trade.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Automotive M&A | 1 of 1 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 1 of 1 |
| Country: Turkey M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
